Detalhe da pesquisa
1.
A Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation.
Crit Care Med
; 50(9): 1348-1359, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583232
2.
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.
Cancer Cell
; 37(1): 37-54.e9, 2020 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883968
3.
Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib.
Clin Cancer Res
; 24(11): 2594-2604, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298799
4.
NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model.
Cancer Res
; 78(13): 3709-3717, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760044
5.
BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer.
Cancer Immunol Res
; 6(10): 1234-1245, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30087114
6.
Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer.
Clin Cancer Res
; 24(19): 4854-4864, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945997
7.
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.
Cancer Discov
; 8(2): 196-215, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101162
8.
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.
Cancer Discov
; 8(2): 216-233, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101163
9.
Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma.
Cancer Res
; 77(18): 5068-5076, 2017 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754670